Terms: = Head and neck cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Staging
11 results:
1. Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer.
Semsar-Kazerooni K; Morand GB; Payne AE; da Silva SD; Forest VI; Hier MP; Pusztaszeri MP; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2022 Mar; 51(1):9. PubMed ID: 35246262
[TBL] [Abstract] [Full Text] [Related]
2. BRAF
Bakkar S; Macerola E; Aljarrah Q; Proietti A; Materazzi G; Basolo F; Miccoli P
Updates Surg; 2019 Dec; 71(4):701-704. PubMed ID: 31586312
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules.
Goldner WS; Angell TE; McAdoo SL; Babiarz J; Sadow PM; Nabhan FA; Nasr C; Kloos RT
Thyroid; 2019 Nov; 29(11):1594-1605. PubMed ID: 31469053
[No Abstract] [Full Text] [Related]
4. Characterization and effects of miR-21 expression in esophageal cancer.
Wen SW; Zhang YF; Li Y; Liu ZX; Lv HL; Li ZH; Xu YZ; Zhu YG; Tian ZQ
Genet Mol Res; 2015 Aug; 14(3):8810-8. PubMed ID: 26345812
[TBL] [Abstract] [Full Text] [Related]
5. MAPK/ERK-dependent translation factor hyperactivation and dysregulated laminin γ2 expression in oral dysplasia and squamous cell carcinoma.
Degen M; Natarajan E; Barron P; Widlund HR; Rheinwald JG
Am J Pathol; 2012 Jun; 180(6):2462-78. PubMed ID: 22546478
[TBL] [Abstract] [Full Text] [Related]
6. Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma.
Pinto AE; Silva G; Banito A; Leite V; Soares J
Oncol Rep; 2008 Oct; 20(4):913-9. PubMed ID: 18813835
[TBL] [Abstract] [Full Text] [Related]
7. High level of galectin-1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas.
Saussez S; Decaestecker C; Lorfevre F; Cucu DR; Mortuaire G; Chevalier D; Wacreniez A; Kaltner H; André S; Toubeau G; Camby I; Gabius HJ; Kiss R
Int J Oncol; 2007 May; 30(5):1109-17. PubMed ID: 17390012
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer.
Ahrendt SA; Yang SC; Wu L; Westra WH; Jen J; Califano JA; Sidransky D
Clin Cancer Res; 1997 Jul; 3(7):1207-14. PubMed ID: 9815801
[TBL] [Abstract] [Full Text] [Related]
9. Thyroid carcinoma.
Gillenwater AM; Weber RS
Cancer Treat Res; 1997; 90():149-69. PubMed ID: 9367082
[TBL] [Abstract] [Full Text] [Related]
10. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract] [Full Text] [Related]
11. Loss of allelic heterozygosity at the harvey ras locus in human oral carcinomas.
Saranath D; Bhoite LT; Mehta AR; Sanghavi V; Deo MG
J Cancer Res Clin Oncol; 1991; 117(5):484-8. PubMed ID: 1679760
[TBL] [Abstract] [Full Text] [Related]
